• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对性侵犯幸存者进行HIV暴露后预防的前瞻性队列研究。

Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors.

作者信息

Loutfy Mona Rafik, Macdonald Sheila, Myhr Terri, Husson Heather, Du Mont Janice, Balla Shannon, Antoniou Tony, Rachlis Anita

机构信息

Department of Medicine, University of Toronto, Ontario, Canada.

出版信息

Antivir Ther. 2008;13(1):87-95. doi: 10.1177/135965350801300109.

DOI:10.1177/135965350801300109
PMID:18389902
Abstract

BACKGROUND

There is a lack of standardized programs for HIV counselling and post-exposure prophylaxis (PEP) in the setting of sexual assault.

METHODS

We conducted an 18-month prospective cohort study assessing universal HIV counselling for all sexual assault survivors presenting to 18 Ontario Sexual Assault Treatment Centres. HIV PEP was universally offered to those at risk of HIV infection (high risk or unknown risk) presenting < or =72 h after the assault, using Combivir one pill and Kaletra three capsules twice a day for 28 days. Those who accepted HIV PEP were monitored via a schedule of frequent follow ups. The primary outcomes were acceptance and completion rates, and their predictors were determined using multivariable logistic regression. Adverse events (AE) were categorized using a standardized toxicity grading system.

RESULTS

Of the 900 evaluable participants eligible for PEP, 798 (69 at high risk and 729 at unknown risk) were offered treatment. Acceptance rates were 66.7% (n=46) and 41.3% (n=301) for participants at high risk and unknown risk, respectively. Participants at high risk were 2.2 times more likely to accept PEP than those at unknown risk (adjusted odds ratio 2.2; 95% confidence interval 1.2-4.0; P=0.01). Overall, 23.9% high-risk (n=11) and 33.2% unknown-risk participants (n=100) completed PEP (P=0.20). Predictors of acceptance and completion included assault by a stranger and participant anxiety. AEs were common, with 77.1% of participants reporting grade 2-4 symptoms.

CONCLUSION

A province-wide standardized program of universal HIV counselling and offering of PEP to sexual assault survivors with frequent follow up was successfully implemented and feasible.

摘要

背景

在性侵犯情况下,缺乏针对艾滋病毒咨询和暴露后预防(PEP)的标准化方案。

方法

我们进行了一项为期18个月的前瞻性队列研究,评估为前往安大略省18个性侵犯治疗中心的所有性侵犯幸存者提供的普遍艾滋病毒咨询。对于在性侵犯后≤72小时出现艾滋病毒感染风险(高风险或风险不明)的人,普遍提供艾滋病毒PEP,使用双汰芝1片和克力芝3粒胶囊,每天两次,共28天。接受艾滋病毒PEP的人通过定期随访进行监测。主要结局是接受率和完成率,并使用多变量逻辑回归确定其预测因素。不良事件(AE)使用标准化毒性分级系统进行分类。

结果

在900名符合PEP条件的可评估参与者中,798人(69人高风险,729人风险不明)接受了治疗。高风险参与者和风险不明参与者的接受率分别为66.7%(n = 46)和41.3%(n = 301)。高风险参与者接受PEP的可能性是风险不明参与者的2.2倍(调整后的优势比为2.2;95%置信区间为1.2 - 4.0;P = 0.01)。总体而言,23.9%的高风险参与者(n = 11)和33.2%的风险不明参与者(n = 100)完成了PEP(P = 0.20)。接受和完成的预测因素包括陌生人实施的性侵犯和参与者焦虑。不良事件很常见,77.1%的参与者报告有2 - 4级症状。

结论

成功实施了一项全省范围的标准化方案,为性侵犯幸存者提供普遍的艾滋病毒咨询并提供PEP,并进行频繁随访,该方案是可行的。

相似文献

1
Prospective cohort study of HIV post-exposure prophylaxis for sexual assault survivors.对性侵犯幸存者进行HIV暴露后预防的前瞻性队列研究。
Antivir Ther. 2008;13(1):87-95. doi: 10.1177/135965350801300109.
2
Adverse events and adherence to HIV post-exposure prophylaxis: a cohort study at the Korle-Bu Teaching Hospital in Accra, Ghana.不良事件与艾滋病毒暴露后预防的依从性:加纳阿克拉科勒-布教学医院的一项队列研究
BMC Public Health. 2015 Jun 20;15:573. doi: 10.1186/s12889-015-1928-6.
3
Postexposure prophylaxis for HIV after sexual assault.性侵犯后HIV暴露后预防。
JAMA. 2000 Sep 27;284(12):1516-8. doi: 10.1001/jama.284.12.1516-a.
4
Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center.性侵犯后儿童和青少年的HIV暴露后预防:在一家城市医疗中心进行的前瞻性观察研究。
Sex Transm Dis. 2007 Feb;34(2):65-8. doi: 10.1097/01.olq.0000225329.07765.d8.
5
Non-occupational postexposure prophylaxis for HIV: a systematic review.HIV的非职业性暴露后预防:一项系统综述。
Health Technol Assess. 2009 Feb;13(14):iii, ix-x, 1-60. doi: 10.3310/hta13140.
6
Single-tablet regimen of emtricitabine/tenofovir disoproxil fumarate plus cobicistat-boosted elvitegravir increase adherence for HIV postexposure prophylaxis in sexual assault victims.恩曲他滨/替诺福韦二吡呋酯单片复方制剂联合考比司他增强的艾维雷韦替拉韦用于性侵受害者 HIV 暴露后预防可提高服药依从性。
Sex Transm Infect. 2021 Aug;97(5):329-333. doi: 10.1136/sextrans-2020-054714. Epub 2020 Oct 26.
7
Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims.人类免疫缺陷病毒暴露后预防措施在青少年性侵犯受害者中的应用。
Arch Pediatr Adolesc Med. 2006 Jul;160(7):674-80. doi: 10.1001/archpedi.160.7.674.
8
Sexual Assault and HIV Postexposure Prophylaxis at an Urban African Hospital.一家城市非洲医院的性侵犯与艾滋病毒暴露后预防
AIDS Patient Care STDS. 2017 Jun;31(6):255-260. doi: 10.1089/apc.2016.0274.
9
Randomized controlled trial of the tolerability and completion of maraviroc compared with Kaletra® in combination with Truvada® for HIV post-exposure prophylaxis (MiPEP Trial).马拉维若与克力芝联合特鲁瓦达用于HIV暴露后预防的耐受性及完成情况的随机对照试验(MiPEP试验)
J Antimicrob Chemother. 2017 Jun 1;72(6):1760-1768. doi: 10.1093/jac/dkx062.
10
Post-exposure prophylaxis for human immunodeficiency virus after sexual assault in a Midwestern U.S. emergency department.美国中西部一急诊部门发生性侵犯后艾滋病毒暴露后预防。
Am J Emerg Med. 2021 Nov;49:117-123. doi: 10.1016/j.ajem.2021.05.070. Epub 2021 Jun 1.

引用本文的文献

1
Updated guidelines on HIV post-exposure prophylaxis: continued efforts towards increased accessibility.HIV 暴露后预防指南更新:持续努力提高可及性。
J Int AIDS Soc. 2024 Nov;27(11):e26393. doi: 10.1002/jia2.26393.
2
Readiness for HIV Postexposure Prophylaxis (PEP) Decision Making Following Sexual Violence.性暴力后艾滋病病毒暴露前预防(PEP)决策准备。
Issues Ment Health Nurs. 2024 Sep;45(9):937-947. doi: 10.1080/01612840.2024.2366324. Epub 2024 Aug 22.
3
Missed Opportunities: A Narrative Review on Why Nonoccupational Postexposure Prophylaxis for HIV Is Underutilized.
错失的机会:关于为何未充分利用非职业性HIV暴露后预防的叙述性综述。
Open Forum Infect Dis. 2024 Jun 15;11(8):ofae332. doi: 10.1093/ofid/ofae332. eCollection 2024 Aug.
4
Adherence, adverse drug reactions, and discontinuation associated with adverse drug reactions of HIV post-exposure prophylaxis: a meta-analysis based on cohort studies.HIV 暴露后预防药物的依从性、不良反应及与不良反应相关的停药:基于队列研究的荟萃分析。
Ann Med. 2023;55(2):2288309. doi: 10.1080/07853890.2023.2288309. Epub 2023 Dec 8.
5
Patient and Provider Decision Making About HIV Postexposure Prophylaxis Following Sexual Violence: A Qualitative Analysis.患者和提供者在性暴力后决定是否接受 HIV 暴露后预防的决策:定性分析。
J Assoc Nurses AIDS Care. 2023;34(6):566-581. doi: 10.1097/JNC.0000000000000430. Epub 2023 Sep 28.
6
"Reclaiming Control" Patient Acceptance and Adherence to HIV Post-Exposure Prophylaxis Following Sexual Assault.“重新掌控局面”:性侵犯后患者对HIV暴露后预防的接受与依从情况
Glob Qual Nurs Res. 2021 Nov 3;8:23333936211046581. doi: 10.1177/23333936211046581. eCollection 2021 Jan-Dec.
7
Sexually Transmitted Infections Treatment Guidelines, 2021.《2021年性传播感染治疗指南》
MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. doi: 10.15585/mmwr.rr7004a1.
8
Post-exposure prophylaxis for HIV infection in sexual assault victims.HIV 感染后暴露于性侵犯受害者的预防措施。
HIV Med. 2020 Jan;21(1):43-52. doi: 10.1111/hiv.12797. Epub 2019 Oct 11.
9
The use of HIV post-exposure prophylaxis in forensic medicine following incidents of sexual violence in Hamburg, Germany: a retrospective study.德国汉堡性暴力事件后法医学中HIV暴露后预防的应用:一项回顾性研究
Forensic Sci Med Pathol. 2018 Sep;14(3):332-341. doi: 10.1007/s12024-018-9985-7. Epub 2018 May 18.
10
Exploring Receipt of HIV PEP Counseling Among Women Sexually Assaulted by an Intimate Partner.探索亲密伴侣性侵犯女性中接受HIV暴露后预防咨询的情况。
Open AIDS J. 2018 Jan 31;12:1-5. doi: 10.2174/1874613601812010001. eCollection 2018.